These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 19506389)

  • 1. Pretransplant positivity for circulating thyroid antibodies and graft survival in patients undergoing kidney transplant.
    Rotondi M; Leporati P; Lodigiani S; Netti GS; Precerutti S; Magri F; Rosati A; Pradella F; Salvadori M; Serio M; Romagnani P; Chiovato L
    Horm Res; 2009; 71(6):324-30. PubMed ID: 19506389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.
    He X; Johnston A
    Transplant Proc; 2004 Dec; 36(10):2993-6. PubMed ID: 15686679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.
    Roos M; Heinemann FM; Lindemann M; Horn PA; Lutz J; Stock K; Thürmel K; Baumann M; Witzke O; Heemann U
    Kidney Blood Press Res; 2011; 34(5):328-33. PubMed ID: 21613794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretransplant serum FT3 levels in kidney graft recipients are useful for identifying patients with higher risk for graft failure.
    Rotondi M; Netti GS; Rosati A; Mazzinghi B; Magri F; Ronconi E; Becherucci F; Pradella F; Salvadori M; Serio M; Romagnani P; Chiovato L
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):220-5. PubMed ID: 17803692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome.
    Ismail AM; Badawi RM; El-Agroudy AE; Mansour MA
    Exp Clin Transplant; 2009 Jun; 7(2):104-9. PubMed ID: 19715514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
    Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
    Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection.
    Crescioli C; Buonamano A; Scolletta S; Sottili M; Francalanci M; Giomarelli P; Biagioli B; Lisi G; Pradella F; Serio M; Romagnani P; Maccherini M
    Transplantation; 2009 Jan; 87(2):249-55. PubMed ID: 19155980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report.
    Süsal C; Döhler B; Sadeghi M; Ovens J; Opelz G
    Transplantation; 2009 May; 87(9):1367-71. PubMed ID: 19424037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient and graft survival of kidney allograft recipients with minimal hepatitis C virus infection: a case-control study.
    Shahbazian H; Hajiani E; Ehsanpour A
    Urol J; 2008; 5(3):178-83. PubMed ID: 18825625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.
    Heldal K; Hartmann A; Leivestad T; Svendsen MV; Foss A; Lien B; Midtvedt K
    Transplantation; 2009 Apr; 87(7):1045-51. PubMed ID: 19352126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C, acute humoral rejection, and renal allograft survival.
    Forman JP; Tolkoff-Rubin N; Pascual M; Lin J
    J Am Soc Nephrol; 2004 Dec; 15(12):3249-55. PubMed ID: 15579529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection.
    Reinsmoen NL; Cornett KM; Kloehn R; Burnette AD; McHugh L; Flewellen BK; Matas A; Savik K
    Transplantation; 2008 Feb; 85(3):462-70. PubMed ID: 18301338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-related autoantibodies in Tunisian patients with type 1 diabetes.
    Sakly W; Mankaï A; Achour A; Thabet Y; Ouertani M; Boughammoura L; Harbi A; Chaieb L; Sfar MT; Ghedira I
    Endocr Res; 2012; 37(2):59-66. PubMed ID: 22149460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First year renal function as a predictor of kidney allograft outcome.
    Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG
    Transplant Proc; 2009 Apr; 41(3):846-8. PubMed ID: 19376368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients.
    Sadeghi M; Daniel V; Naujokat C; Mehrabi A; Opelz G
    Transplantation; 2006 Jun; 81(12):1716-24. PubMed ID: 16794539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients.
    Sadeghi M; Daniel V; Lahdou I; Döhler B; Naujokat C; Renner FC; Weimer R; Fonouni H; Mehrabi A; Schmidt J; Schenk M; Zeier M; Opelz G
    Transplantation; 2009 Jul; 88(2):266-71. PubMed ID: 19623024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.